Your browser doesn't support javascript.
loading
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.
Mariz, Filipe Colaço; Gray, Penelope; Bender, Noemi; Eriksson, Tiina; Kann, Hanna; Apter, Dan; Paavonen, Jorma; Pajunen, Emma; Prager, Kristina M; Sehr, Peter; Surcel, Heljä-Marja; Waterboer, Tim; Müller, Martin; Pawlita, Michael; Lehtinen, Matti.
Afiliação
  • Mariz FC; Tumorvirus-Specific Vaccination Strategies, Deutsches Krebsforschungszentrum, Heidelberg, Germany. Electronic address: f.mariz@dkfz.de.
  • Gray P; Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Bender N; Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Eriksson T; FICAN-Mid, Pirkanmaan Sairaanhoitopiiri, Research, Development and Innovation Centre Nuorisotutkimusasema, Tampere, Finland.
  • Kann H; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
  • Apter D; VL-Medi, Helsinki, Finland.
  • Paavonen J; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki, Finland.
  • Pajunen E; ESIS-EEIG, Luhtaankatu, Tampere, Finland.
  • Prager KM; Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Sehr P; EMBL-DKFZ Chemical Biology Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Surcel HM; Biobank Borealis of Northern Finland, Oulu University Hospital, Oulu, Finland; Faculty of Medicine, University of Oulu, Oulu, Finland.
  • Waterboer T; Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Müller M; Tumorvirus-Specific Vaccination Strategies, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Pawlita M; Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Lehtinen M; Infections and Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany; FICAN-Mid, Pirkanmaan Sairaanhoitopiiri, Research, Development and Innovation Centre Nuorisotutkimusasema, Tampere, Finland; Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
Lancet Infect Dis ; 21(10): 1458-1468, 2021 10.
Article em En | MEDLINE | ID: mdl-34081923
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus / Anticorpos Neutralizantes / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article